通过mRNA纳米递送恢复野生类型p53的治疗潜力来对抗癌症
Divya Kamath1, Tomoo Iwakuma2, Stefan H Bossmann1
1The University of Kansas Medical Center, Department of Cancer Biology, 3901 Rainbow Blvd, mailstop 1071, 66160 Kansas City, KS, USA.
Nanomedicine : nanotechnology, biology, and medicine
|January 10, 2024
概括
TP53突变在癌症中很常见,导致瘤抑制的丧失和新的促进癌症的功能. 使用mRNA纳米医学恢复野生型p53 (WTp53) 功能,为癌症提供了有前途的新疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 纳米医学是一种纳米医学.
背景情况:
- TP53是人类癌症中最常发生突变的瘤抑制基因.
- 突变通常会导致错误的突变,产生突变p53 (mutp53) 蛋白质.
- mutp53获得了促进癌症转移和进展的致癌功能.
研究的目的:
- 审查TP53突变在癌症中的作用.
- 探索恢复野生型p53 (WTp53) 功能的治疗潜力.
- 为突出mRNA纳米医学在癌症治疗中的进展.
主要方法:
- 关于TP53突变在癌症中的作用的文献综述.
- 讨论针对突变p53.3的治疗策略.
- 探索mRNA纳米医学应用.
主要成果:
- TP53突变导致瘤抑制功能的丧失和瘤原性功能的增加.
- 目前针对TP53的治疗方法取得的成功有限.
- mRNA纳米医学为p53恢复提供了一种新的方法.
结论:
- 恢复WTp53或耗尽mutp53的向疗法对于癌症治疗至关重要.
- mRNA纳米医学具有恢复WTp53功能的巨大潜力.
- 纳米医学的进步为有效的癌症治疗提供了新的途径.
更多相关视频
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
28.3K
08:29Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
10.1K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
